These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 805967)

  • 1. [Proceedings: Elevation of transaminases following treatment with chenodeoxycholic acid: dependence on chenodeoxycholic acid dosage and on serum chenodeoxycholic acid concentration].
    Stiehl A; Regula M; Kommerell B
    MMW Munch Med Wochenschr; 1975 May; 117(20):840. PubMed ID: 805967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Increase of transaminases following chenodeoxycholic acid treatment: relation of chenodeoxycholic acid dosage to serum chenodeoxycholic acid concentration].
    Stiehl A; Regula M; Kommerell B
    Verh Dtsch Ges Inn Med; 1975; 81():1308. PubMed ID: 1229471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum transaminases and bile acid concentrations in the serum of patients with biliary calculi during treatment with chenodeoxycholic acid].
    Stiehl A; Ast E; Czygan P; Fröhling W; Kommerell B
    Z Gastroenterol Verh; 1976; (9):40-1. PubMed ID: 64083
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity of chenodeoxycholic acid in the rhesus monkey.
    Dyrszka H; Chen T; Salen G; Mosbach EH
    Gastroenterology; 1975 Aug; 69(2):333-7. PubMed ID: 1150041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical treatment of cholelithiasis by chenodeoxycholic acid. Chenodeoxycholic acid biotransformation and significance of lithocholic acid sulphate (author's transl)].
    Hrabák P; Dosková M; Soucková E; Konecný K; Holásková M
    Cas Lek Cesk; 1979 Aug; 118(35):1078-82. PubMed ID: 519676
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical treatment of cholelithiasis with chenodeoxycholic acid. Preliminary experiences with various dosage schedules].
    Garagnani A; Evangelisti GB; Faggioli M; Mazzetti M
    Clin Ter; 1975 Mar; 72(5):435-44. PubMed ID: 773591
    [No Abstract]   [Full Text] [Related]  

  • 8. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
    Arnfred T; Pedersen L
    Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increasing sulfatization of lithocholic acid during chenodeoxycholic acid treatment].
    Raedsch R; Stiehl A
    Verh Dtsch Ges Inn Med; 1974; 80():447-8. PubMed ID: 4454582
    [No Abstract]   [Full Text] [Related]  

  • 10. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: The effects of different doses of chenodeoxycholic acid and of withdrawing treatment on bile lipid composition and liver function in patients with gallstones.
    Mok HY; Bell GD; Dowling RH
    Gut; 1974 Apr; 15(4):340. PubMed ID: 4834569
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role and limitations of litholytic therapy of cholesterin cholecystolithiasis. Results in 86 cases treated with chenic acid].
    Mortola GP; Anfossi A; Parodi E; Cafiero F; Pezzoli F; Berti Riboli E
    Minerva Med; 1980 Sep; 71(32):2283-91. PubMed ID: 7432661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Factors determining gallstone dissolution in patients treated with chenodeoxycholic acid (CDCA).
    Iser J; Mok HY; Bell GD; Dowling RH
    Gut; 1975 May; 16(5):394. PubMed ID: 1140643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conservative treatment of cholelithiasis with chenodeoxycholic and ursodeoxycholic acid preparations].
    Golochevskaia VS; Genia LP
    Klin Med (Mosk); 1992; 70(7-8):60-3. PubMed ID: 1460833
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of cholelithiasis with chenodeoxycholic acid].
    Keclík M
    Vnitr Lek; 1975 Feb; 21(2):177-82. PubMed ID: 1114723
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug treatment of cholelithiasis with chenodeoxycholic and ursodeoxycholic acids (review of the foreign literature)].
    Georgadze AK; Karpov VI; Korotkov VV
    Klin Med (Mosk); 1987 Jan; 65(1):32-7. PubMed ID: 3550280
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
    Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
    Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
    Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
    Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term use of chenodeoxycholic acid in patients with cholelithiasis].
    Mansurov KhKh; Mansurova FKh
    Ter Arkh; 1984; 56(1):43-7. PubMed ID: 6710375
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Lithocholate kinetics in patients ingesting chenodeoxycholic (chenic) acid for gall stone dissolution.
    Allan R; Hofmann AF
    Gut; 1976 May; 17(5):394. PubMed ID: 1278751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.